Clinical use of inotropic agents.
نویسندگان
چکیده
منابع مشابه
The Cardioprotective Effects of N acetylcysteine as an Additive to the Blood Cardioplegia During Coronary Artery Bypass Grafting
Introduction: During coronary artery bypass graft (CABG) surgery with cardiopulmonary bypass (CPB), the role of cardioplegic solution which results in cardiac arrest, is critical. This study was planned to evaluate the clinical impacts of N acetylcysteine (NAC) enriched cold-blood cardioplegia on early reperfusion injury in patients with ischaemic heart disease undergoing CABG Methods: In a...
متن کاملHome inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
STUDY OBJECTIVES This study was conducted to assess cost savings and clinical outcomes associated with the use of home i.v. inotropic therapy in patients with advanced (New York Heart Association [NYHA] class IV) heart failure. DESIGN Retrospective analysis. SETTING Tertiary care referral center. PATIENTS AND INTERVENTIONS Twenty-four patients (13 men, 11 women; age, 61+/-12 years) with l...
متن کاملHospital patterns of use of positive inotropic agents in patients with heart failure.
OBJECTIVES This study sought to determine hospital variation in the use of positive inotropic agents in patients with heart failure. BACKGROUND Clinical guidelines recommend targeted use of positive inotropic agents in highly selected patients, but data are limited and the recommendations are not specific. METHODS We analyzed data from 376 hospitals including 189,948 hospitalizations for he...
متن کاملHome Inotropic Therapy in Advanced Heart Failure
Study objectives: This study was conducted to assess cost savings and clinical outcomes associated with the use of home IV inotropic therapy in patients with advanced (New York Heart Association [NYHA] class IV) heart failure. Design: Retrospective analysis. Setting: Tertiary care referral center. Patients and interventions: Twenty-four patients (13 men, 11 women; age, 61 ±12 years) with left v...
متن کاملLevosimendan: beyond its simple inotropic effect in heart failure.
Classic inotropic agents provide short-term haemodynamic improvement in patients with heart failure, but their use has been associated with poor prognosis. A new category of inotropic agents, the Ca(2+) sensitizers, may provide an alternative longer lasting solution. Levosimendan is a relatively new Ca(2+) sensitizer which offers haemodynamic and symptomatic improvement by combining a positive ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- AANA journal
دوره 47 6 شماره
صفحات -
تاریخ انتشار 1979